CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression
Cancers · 05.11.2025 · 17 (21) · 3571
DOI: 10.3390/cancers17213571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 05.11.2025. Verfasst von Zhihai Deng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Science and Technology Plan Project of Guangzhou, The Guangdong Provincial Medical Research Fund.
Abstract (Originalsprache)
Background
Prostate cancer, an epithelial malignancy occurring in the prostate, is the most common malignant tumor of the male genitourinary system and has a low survival rate in advanced prostate cancer after metastasis. It is urgent to explore novel therapeutic targets and strategies for treating prostate cancer. Circular RNA (circRNA) and ferroptosis both play critical roles in prostate cancer progression. However, the regulatory effect of circRNA on ferroptosis remains unclear.
Methods
Here, circRNA expression profiles in prostate cancer were explored by bioinformatics analysis and human prostate cancer tissue microarray. Stable circRNA-knockdown or overexpressed prostate cancer cell lines were constructed by lentivirus. AGO2-RNA immunoprecipitation (AGO2-RIP) was utilized to identify circRNA-microRNA (miRNA) interaction.
Results
Results of this study indicate that circATP2C1 is highly expressed in prostate cancer. In addition, circATP2C1 promotes prostate cancer cell proliferation, migration, and invasion by suppressing ferroptosis in vitro. Moreover, circATP2C1 facilitates the tumorigenicity of prostate cancer by inhibiting ferroptosis in vivo.
Conclusions
Mechanistically, circATP2C1 hinders ferroptosis by increasing solute carrier family 7 member 11 (SLC7A11) expression via sponging miR-654-3p. In summary, our findings highlight the oncogenic role of circATP2C1 in prostate cancer and provide novel targets and strategies for treating prostate cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
- Department of Urology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical Unive…
- Department of Pathology, The First Affiliated Hospital of Guangzhou Medical University, 151 West Yanjiang Road, Guangzhou 510120, China.
ORCID-Profile: Xiangming Mao
Förderung
- The National Natural Science Foundation of China
- The Science and Technology Plan Project of Guangzhou
- The Guangdong Provincial Medical Research Fund
Zitieren
APA
Deng, Z., Shen, Q., Deng, N., Wu, J., Cheng, X., Wang, J., Peng, H., Zeng, W., Song, Z., Jiang, D., Lv, D., & Mao, X. (2025). CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression. Cancers, 17(21), 3571. https://doi.org/10.3390/cancers17213571
Vancouver
Deng Z, Shen Q, Deng N, Wu J, Cheng X, Wang J, et al. CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression. Cancers. 2025;17(21):3571. doi:10.3390/cancers17213571
BibTeX
@article{Deng2025,
author = {Deng, Zhihai and Shen, Qiang and Deng, Nan and Wu, Jun and Cheng, Xinghui and Wang, Jiaxing and Peng, Hangyang and Zeng, Weijie and Song, Ziyi and Jiang, Dongmei and Lv, Daojun and Mao, Xiangming},
title = {CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression},
journal = {Cancers},
year = {2025},
volume = {17},
number = {21},
pages = {3571},
doi = {10.3390/cancers17213571}
}
EUVIMED